Obligatory price reductions on generic medicines, introduced in Spain to cut the public deficit, are starting to take their toll. National health service spending on pharmaceuticals fell to €977 in July 2010, down by 6.8% compared to the same month ...
TiGenix, the Belgium based biotech that spunout its drug discovery activities last week, is focused on becoming a development and marketing company, its CEO
Gil Beyen
told Scrip.
The company spun out its drug discovery activities into new company ...
Meda of Sweden is to acquire the US speciality pharma company Alaven Pharmaceutical to enhance its US marketing capabilities and expand its therapeutic focus to include both gastroenterology and women's health, areas it already operates in outside ...
TiGenix, the Belgium-based biotech, has spun out its drug discovery activities into new company Arcarios, which was also formed with the help of the Catholic University of Leuven (KULeuven), Ghent University (UGent), the Dutch biotech firm ...
NICE, the National Institute for health and Clinical Excellence in the UK, will not be recommending Novartis's Glivec (imatinib)as an adjuvant treatment for post surgery gastrointestinal stromal tumour (GIST) patients at risk of the cancer ...
